NCT06121453

Adherence Intervention in Patients With Metastatic Breast Cancer

P50 Supplement: Improving Medications Adherence Equitably Among Patients With Metastatic Breast Cancer and Cardiovascular Disease

• Status: Suspended
• Phase: N/A
• Study type: Interventional
• Enrollment: 35 (estimated)
• Sponsor: Columbia University · Academic / Other
• Sex: All
• Age: 18 Years – 99 Years
• Healthy volunteers: Not accepted

Summary

To evaluate the preliminary efficacy of a multicomponent adherence intervention focused on enhancing digital equity and pharmaco-equity among nonadherent patients with metastatic breast cancer (MBC) and cardiovascular disease (CVD) risk factors on endocrine therapy (ET), CDK4/6 inhibitor (CDK 4/6i), and CVD medications. To assess the acceptability and appropriateness of this intervention in patients with MBC and CVD risk factors through validated measures of implementation outcomes. To gain a deeper understanding of the impact of social determinants of health (SDOH) on medication nonadherence through semi-structured interviews with a subset of study participants.

Conditions

• Breast Cancer

Interventions

Type	Name	Description
BEHAVIORAL	Multicomponent Adherence Intervention	multi-part intervention to reduce barriers to medication use

Timeline

• Start date: 2024-04-12
• Primary completion: 2026-11-10
• Completion: 2026-12-10
• First posted: 2023-11-08
• Last updated: 2025-05-22

Locations

1 site across 1 country: United States